ArticleMovement disorders clinical practice2026

Evaluating the Role of α-Synuclein Seed Amplification as a Disease Progression Marker: Evidence and Uncertainties.

Daniel Belete et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.